Fig. 2From: Evaluation of MiR-1908-3p as a novel serum biomarker for breast cancer and analysis its oncogenic function and target genesSerum miR-1908-3p level is increased in breast cancer patients compared with healthy donors. a The serum miR-1908-3p level in 60 breast cancer patients and 60 healthy donors were determined by RT-qPCR. Quantification of miR-1908-3p expression were calculated with the 2-∆Ct method. b High levels of serum miR-1908-3p as a diagnostic marker in patients with breast cancer based on 60 breast cancer patients and 60 healthy donors.***, p < 0.001Back to article page